{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:58:43Z","timestamp":1792061923111,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tim.2024.12.006","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T15:17:52Z","timestamp":1736954272000},"page":"1155-1162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Strengthening serological studies: the need for greater geographical diversity, biobanking, and data-accessibility"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-4071","authenticated-orcid":false,"given":"Arthur","family":"Menezes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solohery Lalaina","family":"Razafimahatratra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oghenebrume","family":"Wariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Jessica E.","family":"Metcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2024.12.006_bb0005","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"Cutts","year":"2016","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.tim.2024.12.006_bb0010","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0140-6736(16)30164-7","article-title":"Use of serological surveys to generate key insights into the changing global landscape of infectious disease","volume":"388","author":"Metcalf","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tim.2024.12.006_bb0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/infdis\/jiy137","article-title":"Benefits and challenges in using seroprevalence data to inform models for measles and rubella elimination","volume":"218","author":"Winter","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2024.12.006_bb0020","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1038\/s41598-022-14493-3","article-title":"Leveraging a national biorepository in Zambia to assess measles and rubella immunity gaps across age and space","volume":"12","author":"Carcelen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2024.12.006_bb0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.tim.2020.04.009","article-title":"Using serology to anticipate measles post-honeymoon period outbreaks","volume":"28","author":"Metcalf","year":"2020","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.tim.2024.12.006_bb0030","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3390\/vaccines10091407","article-title":"Serological and molecular survey for dengue virus infection in suspected febrile patients in selected Local Government Areas in Adamawa State, Nigeria","volume":"10","author":"Tizhe","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tim.2024.12.006_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijid.2017.02.016","article-title":"Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia: implications for vaccine introduction","volume":"58","author":"Carabali","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.tim.2024.12.006_bb0040","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12916-020-01833-1","article-title":"A serological framework to investigate acute primary and post-primary dengue cases reporting across the Philippines","volume":"18","author":"Biggs","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.tim.2024.12.006_bb0045","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3390\/v15102065","article-title":"Serological and molecular epidemiology of Chikungunya virus infection in Vietnam, 2017\u20132019","volume":"15","author":"Nguyen","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.tim.2024.12.006_bb0050","article-title":"Serological and molecular evidence of chikungunya virus infection among febrile outpatients seeking healthcare in Northern Malawi","volume":"13","author":"Kawonga","year":"2023","journal-title":"Infect. Ecol. Epidemiol."},{"key":"10.1016\/j.tim.2024.12.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103833","article-title":"Serological evidence of leptospirosis in Iran; a systematic review and meta-analysis","volume":"138","author":"Khalili","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.tim.2024.12.006_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010506","article-title":"Estimating the duration of antibody positivity and likely time of Leptospira infection using data from a cross-sectional serological study in Fiji","volume":"16","author":"Rees","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tim.2024.12.006_bb0065","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(21)02867-1","article-title":"Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis","volume":"399","author":"COVID-19 Forecasting Team","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.tim.2024.12.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.114655","article-title":"Age-stratified infection fatality rate of COVID-19 in the non-elderly population","volume":"216","author":"Pezzullo","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.tim.2024.12.006_bb0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S0950268899003532","article-title":"Sero-epidemiology of rubella in the urban population of Addis Ababa, Ethiopia","volume":"124","author":"Cutts","year":"2000","journal-title":"Epidemiol. Infect."},{"issue":"11","key":"10.1016\/j.tim.2024.12.006_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004107","article-title":"Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: a systematic review and meta-analysis of standardized population-based studies","volume":"19","author":"Bergeri","year":"2022","journal-title":"PLoS Med."},{"key":"10.1016\/j.tim.2024.12.006_bb0085","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1016\/j.vaccine.2014.07.005","article-title":"Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveys","volume":"32","author":"MacNeil","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2024.12.006_bb0090","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4269\/ajtmh.15-0198","article-title":"Strategies for coordination of a serosurvey in parallel with an immunization coverage survey","volume":"93","author":"Travassos","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.tim.2024.12.006_bb0095","first-page":"R17","article-title":"The epidemiology of measles in England and Wales since the 1994 vaccination campaign","volume":"7","author":"Gay","year":"1997","journal-title":"Commun. Dis. Rep. CDR Rev."},{"key":"10.1016\/j.tim.2024.12.006_bb0100","first-page":"R26","article-title":"The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme","volume":"7","author":"Miller","year":"1997","journal-title":"Commun. Dis. Rep. CDR Rev."},{"key":"10.1016\/j.tim.2024.12.006_bb0105","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268822000097","article-title":"Leveraging serology to titrate immunisation programme functionality for diphtheria in Madagascar","volume":"150","author":"Razafimahatratra","year":"2022","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.tim.2024.12.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006601","article-title":"Heterogeneity and longevity of antibody memory to viruses and vaccines","volume":"16","author":"Antia","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tim.2024.12.006_bb0115","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tim.2024.12.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181172","article-title":"The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009\u20132014","volume":"12","author":"Bolotin","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2024.12.006_bb0125","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/aje\/kwy114","article-title":"Revealing measles outbreak risk with a nested immunoglobulin G serosurvey in Madagascar","volume":"187","author":"Winter","year":"2018","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tim.2024.12.006_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002144","article-title":"Impact on epidemic measles of vaccination campaigns triggered by disease outbreaks or serosurveys: a modeling study","volume":"13","author":"Lessler","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.tim.2024.12.006_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007840","article-title":"An open source tool to infer epidemiological and immunological dynamics from serological data: serosolver","volume":"16","author":"Hay","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.tim.2024.12.006_bb0140","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","article-title":"Reconstruction of antibody dynamics and infection histories to evaluate dengue risk","volume":"557","author":"Salje","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tim.2024.12.006_bb0145","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64206","article-title":"Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys","volume":"10","author":"Larremore","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.tim.2024.12.006_bb0150","series-title":"Serodynamics: a review of methods for epidemiological inference using serological data","author":"Hay","year":"2023"},{"key":"10.1016\/j.tim.2024.12.006_bb0155","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3201\/eid2609.201840","article-title":"Seroepidemiologic study designs for determining SARS-COV-2 transmission and immunity","volume":"26","author":"Clapham","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.tim.2024.12.006_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011384","article-title":"serosim: an R package for simulating serological data arising from vaccination, epidemiological and antibody kinetics processes","volume":"19","author":"Menezes","year":"2023","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.tim.2024.12.006_bb0165","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1017\/S0950268809990781","article-title":"Seventy-five years of estimating the force of infection from current status data","volume":"138","author":"Hens","year":"2010","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.tim.2024.12.006_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252617","article-title":"Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis","volume":"16","author":"Bobrovitz","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2024.12.006_bb0175","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/S1473-3099(20)30631-9","article-title":"SeroTracker: a global SARS-CoV-2 seroprevalence dashboard","volume":"21","author":"Arora","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2024.12.006_bb0180","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/risa.12430","article-title":"Systematic review of measles and rubella serology studies","volume":"36","author":"Thompson","year":"2016","journal-title":"Risk Anal."},{"key":"10.1016\/j.tim.2024.12.006_bb0185","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1038\/s41467-020-18450-4","article-title":"A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity","volume":"11","author":"Huang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2024.12.006_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14149","article-title":"Serological markers and long COVID-A rapid systematic review","volume":"54","author":"Collins","year":"2024","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.tim.2024.12.006_bb0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12939-021-01611-2","article-title":"Pandemic inequalities: emerging infectious diseases and health equity","volume":"21","author":"Bambra","year":"2022","journal-title":"Int. J. Equity Health"},{"key":"10.1016\/j.tim.2024.12.006_bb0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12961-020-00560-6","article-title":"Exploring why global health needs are unmet by research efforts: the potential influences of geography, industry and publication incentives","volume":"18","author":"Yegros-Yegros","year":"2020","journal-title":"Health Res. Policy Syst."},{"key":"10.1016\/j.tim.2024.12.006_bb0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coviro.2020.05.009","article-title":"Waning immunity and re-emergence of measles and mumps in the vaccine era","volume":"40","author":"Yang","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.tim.2024.12.006_bb0210","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1073\/pnas.1014394108","article-title":"Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure","volume":"108","author":"Lavine","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2024.12.006_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072086","article-title":"Immune boosting explains regime-shifts in prevaccine-era pertussis dynamics","volume":"8","author":"Lavine","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2024.12.006_bb0220","series-title":"Guidance on Conducting Serosurveys in Support of Measles and Rubella Elimination in the WHO European Region","author":"World Health Organization, Regional Office for Europe","year":"2013"},{"key":"10.1016\/j.tim.2024.12.006_bb0225","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1017\/S0950268818002054","article-title":"Improving measles incidence inference using age-structured serological data","volume":"146","author":"Prada","year":"2018","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.tim.2024.12.006_bb0230","first-page":"696","article-title":"Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus","volume":"80","author":"Deming","year":"2002","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.tim.2024.12.006_bb0235","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","article-title":"Sex and gender differences in the outcomes of vaccination over the life course","volume":"33","author":"Flanagan","year":"2017","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.tim.2024.12.006_bb0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cophys.2018.03.010","article-title":"The evolution of greater humoral immunity in females than males: implications for vaccine efficacy","volume":"6","author":"Fink","year":"2018","journal-title":"Curr. Opin. Physiol."},{"key":"10.1016\/j.tim.2024.12.006_bb0245","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1073\/pnas.1321060111","article-title":"Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination","volume":"111","author":"Furman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2024.12.006_bb0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40249-023-01056-5","article-title":"Associations of socioeconomic status with infectious diseases mediated by lifestyle, environmental pollution and chronic comorbidities: a comprehensive evaluation based on UK Biobank","volume":"12","author":"Ye","year":"2023","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.tim.2024.12.006_bb0255","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3201\/eid2706.210568","article-title":"Seroprevalence of severe acute respiratory syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201","volume":"27","author":"Wiens","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.tim.2024.12.006_bb0260","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.2105\/AJPH.2011.300193","article-title":"An agenda for research on the sustainability of public health programs","volume":"101","author":"Scheirer","year":"2011","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.tim.2024.12.006_bb0265","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tim.2024.12.006_bb0270","doi-asserted-by":"crossref","first-page":"e1004","DOI":"10.1093\/cid\/ciaa1785","article-title":"Serologic testing of US blood donations to identify severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2)-reactive antibodies: December 2019\u2013January 2020","volume":"72","author":"Basavaraju","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2024.12.006_bb0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.11606\/s1518-8787.2020054002643","article-title":"Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil","volume":"54","author":"Amorim Filho","year":"2020","journal-title":"Rev. Saude Publica"},{"key":"10.1016\/j.tim.2024.12.006_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.105045","article-title":"Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection","volume":"146","author":"Butler","year":"2022","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.tim.2024.12.006_bb0285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.abe1916","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors","volume":"371","author":"Uyoga","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.tim.2024.12.006_bb0290","doi-asserted-by":"crossref","first-page":"e1363","DOI":"10.1016\/S2214-109X(21)00361-2","article-title":"Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","volume":"9","author":"Razafimahatratra","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.tim.2024.12.006_bb0295","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268820002800","article-title":"Seroprevalence of pertussis in Madagascar and implications for vaccination","volume":"148","author":"Razafimahatratra","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.tim.2024.12.006_bb0300","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.aaa3662","article-title":"Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality","volume":"348","author":"Mina","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.tim.2024.12.006_bb0305","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.aay6485","article-title":"Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens","volume":"366","author":"Mina","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.tim.2024.12.006_bb0310","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nri.2017.77","article-title":"The theory of disappearing microbiota and the epidemics of chronic diseases","volume":"17","author":"Blaser","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tim.2024.12.006_bb0315","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.tim.2025.01.004","article-title":"Getting ahead of human associated microbial decline in Africa: the urgency of sampling in light of epidemiological transition","volume":"33","author":"Moyo","year":"2025","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.tim.2024.12.006_bb0320","first-page":"229","article-title":"Sero-epidemiological studies of 2009 influenza A(H1N1) pandemic","volume":"85","author":"WHO","year":"2010","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.tim.2024.12.006_bb0325","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-2659.2012.0370a.x","article-title":"Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting","volume":"7","author":"Laurie","year":"2013","journal-title":"Influenza Other Respir. Viruses"}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X24003226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X24003226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T20:51:14Z","timestamp":1762894274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X24003226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0966842X24003226"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2024.12.006","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strengthening serological studies: the need for greater geographical diversity, biobanking, and data-accessibility","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2024.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}